BACKGROUND: African-Americans (AA) have the highest rate of colorectal cancer (CRC) incidence and mortality in the US. CRC in AA is more advanced and right-sided. Although screening has been shown to reduce mortality from CRC in the general US population, AA continue to experience a disproportionately higher CRC death compared to other ethnic groups. This study aimed at assessing the trend of CRC in AA, focusing on the changing pattern of in situ tumors in this ethnic group and how observed trends may guide current and future preventive and treatment strategies. MATERIALS AND METHODS: All pathologic reports from 1959 to 2006 in Howard University Hospital (n = 150,000) were reviewed manually. The pathology reports showing colorectal cancer were carefully reviewed and selected by a GI pathologist. Intraepithelial or intramucosal carcinomas were diagnosed as in situ carcinoma. Reviewed pathological information were entered into Microsoft Excel and checked for duplication and missing data. Differences in situ and advanced cancer by sex, histology, location, and years of diagnosis were assessed by Chi-square test. RESULTS: A total of 1,753 CRC cases were diagnosed in this period. About 56% of the cases were female and 51% of the tumors were left-sided. Mean (SD) age was 66 (13) years. The frequency of in situ tumor was 5.8% in this period. There was no statistically significant difference between in situ and advance tumor by age, sex, and tumor location. The rate of in situ tumor peaked in the 1990s at 8.5% (P = 0.0001). We observed a decade-to-decade increasing rate of right-sided tumors, which started at 36% in the period 1959-1970 and peaked in the period of 2001-2006 at 60% (P = 0.0001). CONCLUSIONS: The recent increasing number of advanced and right-sided tumor in our study is concordant with SEER data and has great importance in developing CRC prevention and treatment strategies for AA population.
BACKGROUND: African-Americans (AA) have the highest rate of colorectal cancer (CRC) incidence and mortality in the US. CRC in AA is more advanced and right-sided. Although screening has been shown to reduce mortality from CRC in the general US population, AA continue to experience a disproportionately higher CRC death compared to other ethnic groups. This study aimed at assessing the trend of CRC in AA, focusing on the changing pattern of in situ tumors in this ethnic group and how observed trends may guide current and future preventive and treatment strategies. MATERIALS AND METHODS: All pathologic reports from 1959 to 2006 in Howard University Hospital (n = 150,000) were reviewed manually. The pathology reports showing colorectal cancer were carefully reviewed and selected by a GI pathologist. Intraepithelial or intramucosal carcinomas were diagnosed as in situ carcinoma. Reviewed pathological information were entered into Microsoft Excel and checked for duplication and missing data. Differences in situ and advanced cancer by sex, histology, location, and years of diagnosis were assessed by Chi-square test. RESULTS: A total of 1,753 CRC cases were diagnosed in this period. About 56% of the cases were female and 51% of the tumors were left-sided. Mean (SD) age was 66 (13) years. The frequency of in situ tumor was 5.8% in this period. There was no statistically significant difference between in situ and advance tumor by age, sex, and tumor location. The rate of in situ tumor peaked in the 1990s at 8.5% (P = 0.0001). We observed a decade-to-decade increasing rate of right-sided tumors, which started at 36% in the period 1959-1970 and peaked in the period of 2001-2006 at 60% (P = 0.0001). CONCLUSIONS: The recent increasing number of advanced and right-sided tumor in our study is concordant with SEER data and has great importance in developing CRC prevention and treatment strategies for AA population.
Authors: V W Chen; C M Fenoglio-Preiser; X C Wu; R J Coates; P Reynolds; D L Wickerham; P Andrews; C Hunter; G Stemmermann; J S Jackson; B K Edwards Journal: Cancer Epidemiol Biomarkers Prev Date: 1997-12 Impact factor: 4.254
Authors: E Mitry; A-M Benhamiche; C Couillault; P Roy; C Faivre-Finn; F Clinard; J Faivre Journal: Eur J Cancer Prev Date: 2002-12 Impact factor: 2.497
Authors: Serdar Yanık; Ayşe Neslin Akkoca; Zeynep Tuba Özdemir; Didem Sözütek; Edip Erdal Yılmaz; Süleyman Sayar Journal: Int J Clin Exp Med Date: 2014-12-15
Authors: David T Rubin; Rishi K Gandhi; Jeremy T Hetzel; Sydney H Kinnear; Andrew Aronsohn; Gordon Wood; Nicole Yadron Journal: Dig Dis Sci Date: 2009-11 Impact factor: 3.199
Authors: Kristin Wallace; Allan DeToma; David N Lewin; Shaoli Sun; Don Rockey; Carolyn D Britten; Jennifer D Wu; Aissatou Ba; Anthony J Alberg; Elizabeth G Hill Journal: Clin Colorectal Cancer Date: 2016-12-07 Impact factor: 4.481
Authors: Kristin Wallace; Elizabeth G Hill; David N Lewin; Grace Williamson; Stephanie Oppenheimer; Marvella E Ford; Michael J Wargovich; Franklin G Berger; Susan W Bolick; Melanie B Thomas; Anthony J Alberg Journal: Cancer Causes Control Date: 2013-01-08 Impact factor: 2.506
Authors: Folasade P May; Cynthia B Whitman; Ksenia Varlyguina; Erica G Bromley; Brennan M R Spiegel Journal: J Cancer Educ Date: 2016-09 Impact factor: 2.037
Authors: Folasade P May; Beth A Glenn; Catherine M Crespi; Ninez Ponce; Brennan M R Spiegel; Roshan Bastani Journal: Cancer Epidemiol Biomarkers Prev Date: 2016-12-29 Impact factor: 4.254
Authors: Kristin Wallace; Katherine R Sterba; Elena Gore; David N Lewin; Marvella E Ford; Melanie B Thomas; Anthony J Alberg Journal: Clin Colorectal Cancer Date: 2013-12 Impact factor: 4.481